Published in Diabet Med on June 01, 2011
Chronic stress, cortisol dysfunction, and pain: a psychoneuroendocrine rationale for stress management in pain rehabilitation. Phys Ther (2014) 2.11
Cardiovascular autonomic neuropathies as complications of diabetes mellitus. Nat Rev Endocrinol (2012) 1.36
What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes. J Cardiovasc Transl Res (2012) 1.17
Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease. J Diabetes Investig (2013) 1.13
Cardiac autonomic imbalance in newly diagnosed and established diabetes is associated with markers of adipose tissue inflammation. Exp Diabetes Res (2011) 1.13
Impact of diabetes on cardiovascular disease: an update. Int J Hypertens (2013) 1.13
A sympathetic neuron autonomous role for Egr3-mediated gene regulation in dendrite morphogenesis and target tissue innervation. J Neurosci (2013) 1.08
The New Age of Sudomotor Function Testing: A Sensitive and Specific Biomarker for Diagnosis, Estimation of Severity, Monitoring Progression, and Regression in Response to Intervention. Front Endocrinol (Lausanne) (2015) 1.04
The conductor of the autonomic orchestra. Front Endocrinol (Lausanne) (2012) 0.96
Diabetic autonomic imbalance and glycemic variability. J Diabetes Sci Technol (2012) 0.96
Effect of bromocriptine-QR (a quick-release formulation of bromocriptine mesylate) on major adverse cardiovascular events in type 2 diabetes subjects. J Am Heart Assoc (2012) 0.90
Hypoglycemia in older people - a less well recognized risk factor for frailty. Aging Dis (2015) 0.89
Cardiorespiratory coupling: common rhythms in cardiac, sympathetic, and respiratory activities. Prog Brain Res (2014) 0.89
Guidelines in the management of diabetic nerve pain: clinical utility of pregabalin. Diabetes Metab Syndr Obes (2013) 0.88
Tests for early diagnosis of cardiovascular autonomic neuropathy: critical analysis and relevance. Front Endocrinol (Lausanne) (2013) 0.88
Autonomic neuropathy in diabetes mellitus. Front Endocrinol (Lausanne) (2014) 0.87
Self Reported Childhood Difficulties, Adult Multimorbidity and Allostatic Load. A Cross-Sectional Analysis of the Norwegian HUNT Study. PLoS One (2015) 0.87
Quantifying interactions between real oscillators with information theory and phase models: application to cardiorespiratory coupling. Phys Rev E Stat Nonlin Soft Matter Phys (2013) 0.86
Metabolic syndrome burden in apparently healthy adolescents is adversely associated with cardiac autonomic modulation--Penn State Children Cohort. Metabolism (2015) 0.85
Autonomic test by EZSCAN in the screening for prediabetes and diabetes. PLoS One (2013) 0.82
Association of serum omentin levels with cardiac autonomic neuropathy in patients with type 2 diabetes mellitus: a hospital-based study. Cardiovasc Diabetol (2015) 0.81
Relationship between autonomic nervous system function and continuous interstitial glucose measurement in patients with type 2 diabetes. J Diabetes Res (2014) 0.81
Heart Rate Variability, Insulin Resistance, and Insulin Sensitivity in Japanese Adults: The Toon Health Study. J Epidemiol (2015) 0.80
Remodelling of the intracardiac ganglia in diabetic Goto-Kakizaki rats: an anatomical study. Cardiovasc Diabetol (2013) 0.79
Inflammation as a Therapeutic Target for Diabetic Neuropathies. Curr Diab Rep (2016) 0.78
The Role of Gut Microflora and the Cholinergic Anti-inflammatory Neuroendocrine System in Diabetes Mellitus. Front Endocrinol (Lausanne) (2016) 0.78
Influence of visceral adiposity on cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus. Diabetes Metab J (2012) 0.77
Heart rate variability analysis using robust period detection. Biomed Eng Online (2014) 0.77
DC Electroacupuncture Effects on Scars and Sutures of a Patient with Postconcussion Paina. Med Acupunct (2016) 0.77
Associations between insulin and heart rate variability in police officers. Am J Hum Biol (2013) 0.75
High Intensity Aerobic Exercise Training Improves Deficits of Cardiovascular Autonomic Function in a Rat Model of Type 1 Diabetes Mellitus with Moderate Hyperglycemia. J Diabetes Res (2016) 0.75
Can coefficient of variation of time-domain analysis be valuable for detecting cardiovascular autonomic neuropathy in young patients with type 1 diabetes: a case control study. BMC Cardiovasc Disord (2017) 0.75
Effect of integrated approach of yoga therapy on autonomic functions in patients with type 2 diabetes. Indian J Endocrinol Metab (2015) 0.75
Grand challenges in diabetes. Front Endocrinol (Lausanne) (2012) 0.75
Cardiovagal modulation and efficacy of aerobic exercise training in obese individuals. Med Sci Sports Exerc (2014) 0.75
Morphologic Changes in Autonomic Nerves in Diabetic Autonomic Neuropathy. Diabetes Metab J (2015) 0.75
The degree of autonomic modulation is associated with the severity of microvascular complications in patients with type 1 diabetes. J Diabetes Sci Technol (2015) 0.75
Editorial: Molecular Mechanism of Neuronal Dysfunction in the Diabetic Brain. Front Endocrinol (Lausanne) (2016) 0.75
Cardiac autonomic testing and treating heart disease. "A clinical perspective". Heart Int (2014) 0.75
Effect of aerobic exercise training on regional blood flow and vascular resistance in diabetic rats. Diabetol Metab Syndr (2015) 0.75
The Relationship between Serum Lipid Fractions and Heart Rate Variability in Diabetic Patients with Statin Therapy. Clujul Med (2014) 0.75
Factors associated with parasympathetic activation following exercise in patients with rheumatoid arthritis: a cross-sectional study. BMC Cardiovasc Disord (2016) 0.75
Transcutaneous vagus nerve stimulation induces tidal melatonin secretion and has an antidiabetic effect in Zucker fatty rats. PLoS One (2015) 0.75
Cardiac autonomic testing and diagnosing heart disease. "A clinical perspective". Heart Int (2014) 0.75
Area asymmetry of heart rate variability signal. Biomed Eng Online (2017) 0.75
Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med (2008) 47.90
Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med (2008) 25.70
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med (2003) 20.06
Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med (2008) 18.27
Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet (2005) 17.31
Nitric oxide and peroxynitrite in health and disease. Physiol Rev (2007) 15.49
Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature (2000) 11.49
Diabetic autonomic neuropathy. Diabetes Care (2003) 6.59
Diabetic cardiovascular autonomic neuropathy. Circulation (2007) 4.58
Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med (2005) 3.84
The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care (2003) 3.18
Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. J Clin Invest (2005) 3.10
The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia (1998) 3.05
Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J Pediatr (2001) 2.98
Prevalence of obstructive sleep apnoea in men with type 2 diabetes. Thorax (2006) 2.46
Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care (2010) 2.42
Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. J Clin Invest (1993) 2.35
Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension (2003) 2.26
Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and nondiabetic population: the MONICA/KORA Augsburg Cohort Study. Diabetes Care (2007) 2.13
Antecedent hypoglycemia impairs autonomic cardiovascular function: implications for rigorous glycemic control. Diabetes (2008) 2.04
Obstructive sleep apnea and metabolic syndrome: alterations in glucose metabolism and inflammation. Proc Am Thorac Soc (2008) 2.02
Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie. Diabetes Care (1997) 1.84
Sleep duration is associated with an increased risk for the prevalence of type 2 diabetes in middle-aged women - The FIN-D2D survey. Sleep Med (2007) 1.78
Sympathetic nerve activity in obstructive sleep apnoea. Acta Physiol Scand (2003) 1.74
Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus. Diabetologia (2004) 1.73
Chronic cardiovascular and renal actions of leptin: role of adrenergic activity. Hypertension (2002) 1.63
Altered cardiac autonomic function may precede insulin resistance in metabolic syndrome. Am J Med (2010) 1.58
Decreased heart rate variability is associated with higher levels of inflammation in middle-aged men. Am Heart J (2008) 1.55
Selective parasympathetic innervation of subcutaneous and intra-abdominal fat--functional implications. J Clin Invest (2002) 1.46
Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention. Toxicol Lett (2003) 1.45
The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program. Diabetes Care (2006) 1.44
Metabolic memory in diabetes--focus on insulin. Diabetes Metab Res Rev (2005) 1.43
Increased sympathetic and decreased parasympathetic activity rather than changes in hypothalamic-pituitary-adrenal axis activity is associated with metabolic abnormalities. J Clin Endocrinol Metab (2010) 1.40
Influence of autonomic nervous system dysfunction on the development of type 2 diabetes: the CARDIA study. Diabetes Care (2003) 1.35
Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin-diabetic rats. Am J Physiol Endocrinol Metab (2007) 1.31
Sleep-disordered breathing in nonobese diabetic subjects with autonomic neuropathy. Eur Respir J (2003) 1.30
Why does diabetic autonomic neuropathy predict IDDM mortality? An analysis from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Res Clin Pract (1996) 1.28
Pathophysiology and treatment of diabetic peripheral neuropathy: the case for diabetic neurovascular function as an essential component. Curr Diabetes Rev (2006) 1.28
Cardiovascular autonomic neuropathy (expiration and inspiration ratio) in type 1 diabetes. Incidence and predictors. J Diabetes Complications (2000) 1.23
A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy. Diabetes Care (2007) 1.21
beta-Adrenergic regulation of IL-6 release from adipose tissue: in vivo and in vitro studies. J Clin Endocrinol Metab (2001) 1.19
Effects of physical training on heart rate variability in diabetic patients with various degrees of cardiovascular autonomic neuropathy. Cardiovasc Res (1997) 1.15
Oxidative stress and antioxidant defense in relation to the severity of diabetic polyneuropathy and cardiovascular autonomic neuropathy. Diabetes Care (2004) 1.15
Neuropathy profile of diabetic patients in a pancreas transplantation program. Neurology (1995) 1.12
Diabetic hypertensive leptin receptor-deficient db/db mice develop cardioregulatory autonomic dysfunction. Hypertension (2008) 1.12
Cold exposure suppresses serum adiponectin levels through sympathetic nerve activation in mice. Obesity (Silver Spring) (2006) 1.08
Selective contribution of diabetes and other cardiovascular risk factors to cardiac autonomic dysfunction in the general population. Exp Clin Endocrinol Diabetes (2006) 1.07
Effects of adiponectin on the renal sympathetic nerve activity and blood pressure in rats. Exp Biol Med (Maywood) (2007) 1.05
Plasma leptin concentrations and cardiac autonomic nervous system in healthy subjects with different body weights. J Clin Endocrinol Metab (2000) 1.02
Autonomic neuropathy increases the risk of obstructive sleep apnea in obese diabetics. Respiration (2007) 1.00
Effect of dog-walking on autonomic nervous activity in senior citizens. Med J Aust (2006) 0.99
Epidemiological evidence of altered cardiac autonomic function in subjects with impaired glucose tolerance but not isolated impaired fasting glucose. J Clin Endocrinol Metab (2007) 0.97
Subclinical inflammation and diabetic polyneuropathy: MONICA/KORA Survey F3 (Augsburg, Germany). Diabetes Care (2009) 0.97
Long-term glycemic control influences the long-lasting effect of hyperglycemia on endothelial function in type 1 diabetes. J Clin Endocrinol Metab (2009) 0.97
Nitrosylated proteins in monocytes as a new marker of oxidative-nitrosative stress in diabetic subjects with macroangiopathy. Exp Clin Endocrinol Diabetes (2008) 0.96
Prevalence and clinical correlates of cardiovascular autonomic and peripheral diabetic neuropathy in patients attending diabetes centers. The Diacan Multicenter Study Group. Diabete Metab (1993) 0.94
Adiponectin depolarizes parvocellular paraventricular nucleus neurons controlling neuroendocrine and autonomic function. Endocrinology (2008) 0.92
Current concepts in targeted therapies for the pathophysiology of diabetic microvascular complications. Vasc Health Risk Manag (2007) 0.92
Autonomic function in sleep apnea patients: increased heart rate variability except during REM sleep in obese patients. Sleep Breath (2007) 0.90
Continuous positive airway pressure treatment for obstructive sleep apnoea reduces resting heart rate but does not affect dysrhythmias: a randomised controlled trial. J Sleep Res (2009) 0.90
Beta-adrenoceptor antagonists suppress elevation in body temperature and increase in plasma IL-6 in rats exposed to open field. Neuroendocrinology (1996) 0.90
Use of heart rate reserve and rating of perceived exertion to prescribe exercise intensity in diabetic autonomic neuropathy. Diabetes Care (2003) 0.90
Effects of cyclooxygenase-2 gene inactivation on cardiac autonomic and left ventricular function in experimental diabetes. Am J Physiol Heart Circ Physiol (2008) 0.89
Adiponectin concentrations in sera from patients with type 2 diabetes are negatively associated with sympathovagal balance as evaluated by power spectral analysis of heart rate variation. Diabetes Care (2004) 0.88
Multilevel interactions between the sympathetic and parasympathetic nervous systems: a minireview. Endocr Regul (2010) 0.88
Effect of irbesartan on nitrotyrosine generation in non-hypertensive diabetic patients. Diabetologia (2004) 0.87
Adiponectin acts in the nucleus of the solitary tract to decrease blood pressure by modulating the excitability of neuropeptide Y neurons. Brain Res (2008) 0.87
Increased myocardial vulnerability and autonomic nervous system imbalance in obstructive sleep apnea syndrome. Respir Med (2006) 0.87
Microalbuminuria and cardiovascular autonomic dysfunction are independently associated with cardiovascular mortality: evidence for distinct pathways: the Hoorn Study. Diabetes Care (2009) 0.86
Effect of glycaemic control on myocardial sympathetic innervation assessed by [123I]metaiodobenzylguanidine scintigraphy: a 4-year prospective study in IDDM patients. Diabetologia (1998) 0.85
Alterations in the autonomic control of heart rate variability in patients with anorexia or bulimia nervosa: correlations between sympathovagal activity, clinical features, and leptin levels. J Endocrinol Invest (2007) 0.85
Prolonged (48-hour) modest hyperinsulinemia decreases nocturnal heart rate variability and attenuates the nocturnal decrease in blood pressure in lean, normotensive humans. J Clin Endocrinol Metab (2006) 0.84
Chronic exercise is associated with enhanced cutaneous blood flow in type 2 diabetes. J Diabetes Complications (2002) 0.83
The role of PPARs in the microvascular dysfunction in diabetes. Vascul Pharmacol (2006) 0.82
Continuous positive airway pressure therapy improves cardiovascular autonomic function for persons with sleep-disordered breathing. Chest (2007) 0.82
Effects of lifestyle modification on the progression of coronary atherosclerosis, autonomic function, and angina--the role of GNB3 C825T polymorphism. Am Heart J (2006) 0.80
Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes (1990) 3.07
Standardized tests of heart rate variability: normal ranges obtained from 309 healthy humans, and effects of age, gender, and heart rate. Clin Auton Res (2001) 2.10
Factors associated with avoidance of severe complications after 25 yr of IDDM. Pittsburgh Epidemiology of Diabetes Complications Study I. Diabetes Care (1990) 1.70
Age- and sex-specific incidence rates of migraine with and without visual aura. Am J Epidemiol (1991) 1.62
An epidemiologic study of headache among adolescents and young adults. JAMA (1989) 1.57
Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Med (1993) 1.51
Problems with gait and posture in neuropathic patients with insulin-dependent diabetes mellitus. Diabet Med (1992) 1.44
Human insulin use and hypoglycaemia: insights from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabet Med (1991) 1.42
Control of chromosome behavior in amphibian oocytes. I. The activity of maturing oocytes inducing chromosome condensation in transplanted brain nuclei. Dev Biol (1973) 1.40
Hypertension as a risk factor for diabetic neuropathy: a prospective study. Diabetes (1997) 1.30
Why does diabetic autonomic neuropathy predict IDDM mortality? An analysis from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Res Clin Pract (1996) 1.28
Parylene flexible neural probes integrated with microfluidic channels. Lab Chip (2005) 1.24
Cardiovascular autonomic neuropathy (expiration and inspiration ratio) in type 1 diabetes. Incidence and predictors. J Diabetes Complications (2000) 1.23
Septicemia in 980 patients at a university hospital in Berlin: prospective studies during 4 selected years between 1979 and 1989. Clin Infect Dis (1992) 1.17
Evaluation of matrix-assisted laser desorption/ionization time of flight mass spectrometry for characterization of Culicoides nubeculosus biting midges. Med Vet Entomol (2010) 1.15
Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials. J Neurol Sci (2001) 1.10
Prevalence of gastrointestinal symptoms in diabetic patients and non-diabetic subjects. Z Gastroenterol (1994) 1.05
The progression of retinopathy over 2 years: the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study. J Diabetes Complications (1995) 1.02
The epidemiology of diabetes complications study. IV. Correlates of diabetic background and proliferative retinopathy. Am J Epidemiol (1991) 0.99
The adenosine A1 receptor antagonist SLV320 reduces myocardial fibrosis in rats with 5/6 nephrectomy without affecting blood pressure. Br J Pharmacol (2007) 0.97
Control of chromosome behavior in amphibian oocytes. II. The effect of inhibitors of RNA and protein synthesis on the induction of chromosome condensation in transplanted brain nuclei by oocyte cytoplasm. J Cell Biol (1976) 0.97
Interferometric coupling of the Keck telescopes with single-mode fibers. Science (2006) 0.96
Corneal confocal microscopy: a new technique for early detection of diabetic neuropathy. Curr Diab Rep (2013) 0.95
Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy. Diabet Med (1999) 0.94
Sildenafil citrate for the treatment of erectile dysfunction in men with Type II diabetes mellitus. Diabetologia (2001) 0.94
Efficacy and safety of pregabalin in treatment refractory patients with various neuropathic pain entities in clinical routine. Int J Clin Pract (2007) 0.92
A simple new non-invasive sweat indicator test for the diagnosis of diabetic neuropathy. Diabet Med (2013) 0.92
[1H-NMR-spectroscopic evidence for the release of N-acetyl-alpha-D-neuraminic acid as the first product of neuraminidase action (author's transl)]. Hoppe Seylers Z Physiol Chem (1980) 0.91
Phenotyping animal models of diabetic neuropathy: a consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab). J Peripher Nerv Syst (2014) 0.89
Cardiovascular autonomic neuropathy contributes to left ventricular diastolic dysfunction in subjects with Type 2 diabetes and impaired glucose tolerance undergoing coronary angiography. Diabet Med (2011) 0.87
Medical strategies to reduce amputation in patients with type 2 diabetes. Diabet Med (2013) 0.86
An analysis of transport, exchange, and binding of sodium and potassium in isolated amphibian follicles and denuded oocytes. J Cell Sci (1977) 0.86
Aberrant stress response associated with severe hypoglycemia in a transgenic mouse model of Alzheimer's disease. J Mol Neurosci (2000) 0.86
Regulation of the amphibian oocyte plasma membrane ion permeability by cytoplasmic factors during the first meiotic division. Dev Biol (1977) 0.85
Characterization of a progestin-binding macromolecule in the amphibian oocyte cytosol. Biochem Biophys Res Commun (1979) 0.84
Urinary 8-epi-PGF2alpha and its endogenous beta-oxidation products (2,3-dinor and 2,3-dinor-5,6-dihydro) as biomarkers of total body oxidative stress. Biochem Biophys Res Commun (2005) 0.83
Selective isolation of Vibrio cholerae neuraminidase using an immobilized 4-(nitrophenyl)oxamic acid. Hoppe Seylers Z Physiol Chem (1977) 0.83
Impairment of cerebral autoregulation in diabetic patients with cardiovascular autonomic neuropathy and orthostatic hypotension. Diabet Med (2003) 0.82
Significance of diagnostic parameters in [13C]octanoic acid gastric emptying breath tests. Isotopes Environ Health Stud (1998) 0.82
Neospora caninum in sheep: a herd case report. Vet Parasitol (2003) 0.82
Management strategies for gastrointestinal, erectile, bladder, and sudomotor dysfunction in patients with diabetes. Diabetes Metab Res Rev (2011) 0.82
The effect of moxonidine on feeding and body fat in obese Zucker rats: role of hypothalamic NPY neurones. Br J Pharmacol (1999) 0.80
Regulation of Ca2+ and cyclic AMP during the first meiotic division in amphibian oocytes by progesterone. J Cyclic Nucleotide Res (1980) 0.80
Utility of skin testing in nutritional assessment: a critical review. JPEN J Parenter Enteral Nutr (1982) 0.80
Evaluation of QT interval length, QT dispersion and myocardial m-iodobenzylguanidine uptake in insulin-dependent diabetic patients with and without autonomic neuropathy. Clin Sci (Lond) (1997) 0.80
IRAS splice variants. Ann N Y Acad Sci (2003) 0.80
Differential activation of T cells by antibody-modulated processing of the flanking sequences of class II-restricted peptides. Int Immunol (1996) 0.79
Intravenous insulin infusion therapies for postoperative coronary artery bypass graft patients. Del Med J (1998) 0.79
A simple deep breathing test reveals altered cerebral autoregulation in type 2 diabetic patients. Diabetologia (2008) 0.79
Erythromycin facilitates postpyloric placement of nasoduodenal feeding tubes in intensive care unit patients: randomized, double-blinded, placebo-controlled trial. JPEN J Parenter Enteral Nutr (1997) 0.79
Peripheral and autonomic nerve function in long-term insulin-dependent diabetes. Diabetes Res (1987) 0.79
MALDI-TOF MS for identification of porcine Brachyspira species. Lett Appl Microbiol (2013) 0.79
Do plasminogen activator inhibitor (PAI-1) or tissue plasminogen activator PAI-1 complexes predict complications in Type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications Study. Diabet Med (2003) 0.78
In vitro phage display in a rat beta cell line: a simple approach for the generation of a single-chain antibody targeting a novel beta cell-specific epitope. Diabetologia (2010) 0.78
Treatment with Actovegin® improves sensory nerve function and pathology in streptozotocin-diabetic rats via mechanisms involving inhibition of PARP activation. Exp Clin Endocrinol Diabetes (2011) 0.78
Effective treatment of symptomatic diabetic polyneuropathy by high-frequency external muscle stimulation. Diabetologia (2005) 0.78
Characteristics of Yersinia enterocolitica biotype 1A strains isolated from patients and asymptomatic carriers. Eur J Clin Microbiol Infect Dis (2013) 0.78
Polyneuropathy in impaired glucose tolerance: is postprandial hyperglycemia the main culprit? A mini-review. Gerontology (2012) 0.78
The role of follicle cells in Rana pipiens oocyte maturation induced by delta 5-pregnenolone. Dev Biol (1979) 0.78
In vitro effects of anthraquinones on rat intestine and uterus. Pharmacology (1988) 0.78
[Costs for acute, stationary treatment of polytrauma patients]. Unfallchirurg (2002) 0.78
Na+ and K+ uptake and exchange by the amphibian oocyte during the first meitotic division. Dev Biol (1980) 0.77
Effect of cannabinoids on estrous cycle, ovulation and reproductive capacity of female A/J mice. Pharmacology (1980) 0.77
Frequency-modulated electromagnetic neural stimulation (FREMS) as a treatment for symptomatic diabetic neuropathy: results from a double-blind, randomised, multicentre, long-term, placebo-controlled clinical trial. Diabetologia (2012) 0.77
Platelet activation in diabetic cardiovascular autonomic neuropathy. Diabet Med (1999) 0.77
[Image reconstruction of the corneal subbasal nerve plexus with extended field of view from focus image stacks of a confocal laser scanning microscope]. Klin Monbl Augenheilkd (2011) 0.77
Altered cerebral regulation in type 2 diabetic patients with cardiac autonomic neuropathy. Diabetologia (2006) 0.77
Angiotensin-converting enzyme inhibition and blood pressure response during total intravenous anaesthesia for minor surgery. Acta Anaesthesiol Scand (2011) 0.76
Elevated platelet activation in type I diabetics with chronic complications under long-term near-normoglycemic control. Haemostasis (1990) 0.76
Species distribution and resistance profiles of coagulase-negative staphylococci isolated from bovine mastitis in Switzerland. Schweiz Arch Tierheilkd (2013) 0.76
Neurophysiological tests in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients with subclinical and symptomatic neuropathy. Diabetologia (1992) 0.75
Caustic-induced upper airway obstruction responsiveness to nebulized adrenaline. Pediatrics (2001) 0.75
Impact of conventional or intensive milk replacer programs on Holstein heifer performance through six months of age and during first lactation. J Dairy Sci (2009) 0.75
[Autonomic diabetic neuropathy of the gastrointestinal tract]. Dtsch Med Wochenschr (1993) 0.75
Lack of association of factor V Leiden and coronary heart disease in individuals with and without diabetes. Diabetes Care (1998) 0.75
[H-NMR spectroscopy. Specificity of microbial sialidases against complex substrates]. Hoppe Seylers Z Physiol Chem (1984) 0.75
Inhibition studies on Vibrio cholerae neuraminidase. Hoppe Seylers Z Physiol Chem (1977) 0.75
Sympathoadrenergic overactivity and lipid metabolism. Cardiovasc Drugs Ther (1996) 0.75
The role of Ca2+ and cyclic nucleotides in progesterone initiation of the meiotic divisions in amphibian oocytes. Life Sci (1981) 0.75
Simultaneous assay of neutral sugars and amino sugars by an automatic sugar analyzer: applications to glycoproteins. Hoppe Seylers Z Physiol Chem (1975) 0.75
The new diagnosis and classification of diabetes mellitus. Del Med J (1998) 0.75
Flexible neural probes with micro-fluidic channels for stable interface with the nervous system. Conf Proc IEEE Eng Med Biol Soc (2004) 0.75
Physiological and clinical implications of decidualization-associated protease activity. Ann N Y Acad Sci (1997) 0.75
Glucose counterregulation in type 1 diabetic patients with decreased symptoms of hypoglycemia after insulin pump treatment. Klin Wochenschr (1991) 0.75
[Arachnoid cyst as the differential diagnosis of ischemic optic neuropathy in type-II diabetes]. Dtsch Med Wochenschr (1995) 0.75
Di- and tri-methoxystyryl derivatives of heterocyclic nitrogen compounds. Arzneimittelforschung (1981) 0.75
Significance of diagnostic parameters in [(13)c]octanoic Acid gastric emptying breath tests*. Isotopes Environ Health Stud (1997) 0.75
Success in strabismus therapy: a literature review. J Am Optom Assoc (1982) 0.75
Oedema extension in cerebral metastasis and correlation with the expression of nitric oxide synthase isozymes (NOS I-III). Anticancer Res (2000) 0.75
Prediction of brain damage in two clinical populations. Percept Mot Skills (1970) 0.75
A comparison between alternative and trade name glucose test strips. Diabetes Care (1995) 0.75
Diversity of polyamine patterns in soft rot pathogens and other plant-associated members of the Enterobacteriaceae. Syst Appl Microbiol (2001) 0.75
DNA excision-repair ability of embryonic fibroblasts measured by UDS and thymine dimer excorporation in four inbred mice strains. J Photochem Photobiol B (1989) 0.75
[Pyrimidines. 8. Synthesis and properties of uracil-4-carbaldehyde hydrazone. The first inner orbital complex of a pyrimidine with copper]. Chem Ber (1970) 0.75
Detection of potent insect antigens for humans: hemoglobins (erythrocruorins) of chironomids. Naturwissenschaften (1980) 0.75
[On pyrimidines. V. 5-Bromouracil-4-carbaldehyde]. Hoppe Seylers Z Physiol Chem (1969) 0.75
[1H-NMR spectroscopy--a potent method for the determination of substrate specificity of sialidases (author's transl)]. Hoppe Seylers Z Physiol Chem (1981) 0.75
[Prospective studies on recent and long-term diabetic neuropathy]. Journ Annu Diabetol Hotel Dieu (1988) 0.75
[Notes on uracil-carbaldehyde-(5)-hydrazone]. Chem Ber (1969) 0.75